USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Launch of Topical and Ready-to-Use Fibrin Sealants Impetus to Growth
08-Dec-2015
Global
Market Research
MB93-01-00-00-00
LS00163-GL-MR_17139
The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed and pipeline products are segmented based on their therapeutic uses, namely, deficiency therapy and operative care. An elaborate discussion on clinical trial timelines and results, along with historical and projected launch timelines, has been provided. The study also discusses key companies such as CSL Behring, LFB, Baxter Healthcare, Takeda, Grifols, and Octapharma.
Executive Summary—Key Findings
Executive Summary—Key Findings (continued)
Key Trends
Companies to Watch
Methodology and Scope
Market Overview—Introduction
Market Overview—Blood Plasma Production
Market Segmentation
Blood Plasma Market Share
Fibrinogen Production
Revenue Forecast
Revenue Forecast Discussion
Supply Chain and Distribution Network
Supply Chain and Distribution Network (continued)
Competitive Landscape—Marketed and Pipeline Products
Competitive Landscape Overview
Marketed Products—Deficiency and Other Therapies
Pipeline Products—Deficiency and Other Therapies
Marketed Products—Operative Care
Marketed Products—Operative Care (continued)
Pipeline Products—Operative Care
Fibrinogen Market—Major On-going/Recently Completed Clinical Trials
Fibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)
Fibrinogen Market—Major On-going/Recently Completed Clinical Trials (continued)
Summary of Key Products to Watch
Summary of Key Products to Watch (continued)
Timeline of Key Events—Launch of Products
Product Dashboard—Haemocomplettan/RiaSTAP (CSL Behring)
Product Dashboard—Clottafact (LFB)
Product Dashboard—Octafibrin (Octapharma)
Product Dashboard—Artiss (Baxter Healthcare)
Product Dashboard—Evarrest (Ethicon)
Product Dashboard—Raplixa (The Medicines Company)
Product Dashboard—FS Grifols (Grifols)
Conclusions
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Sriram Radhakrishnan |
| WIP Number | MB93-01-00-00-00 |
| Is Prebook | No |
Analysis of the Global Fibrinogen Market and Product Pipeline
$6,000.00
Special Price $4,500.00 save 25 %